OTLK

0.38444.14%
JP

Joel Prieve

Senior Vice President of Licensing and M&A

Mr. Joel Prieve serves as Senior Vice President of Licensing and M&A at Outlook Therapeutics, Inc. since December 06, 2023 and served as its Senior Vice President of Commercial Operations since February 2022 until December 06, 2023. Mr. Prieve has experience in commercial operations, most recently in the Xcenda division of AmerisourceBergen as Vice President of Business Development and previously in the IPN Solutions division. Over the course of his career, he has amassed valuable leadership experience in sales management and national account management across oncology and specialty biopharmaceutical markets. His expertise in Group Purchasing Organization (GPO) contracting for retina/ophthalmology markets and his proven track record of successful partnerships for new product launches will be key for Outlook Therapeutics’ advancement of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) towards potential commercialization.

Positions